Abstract

Adenoviral vectors (AdV) developed for treatment of the pulmonary manifestations of cystic fibrosis (CF) can deliver, with high efficiency, transgenes to respiratory epithelial cells grown in culture. This study investigated the efficiency of AdV-mediated gene transfer to murine and human respiratory epithelium in vivo and concluded that the epithelial cells facing the lumen of the respiratory cartilaginous airways (columnar cells) are poorly transduced with AdV. Mechanical injury to the epithelium, however, leads to efficient in vivo gene transfer by exposing a susceptible epithelial subtype (basal cells). Increased gene transfer efficiency in vivo after injury is not a nonspecific response because the proliferative status of the epithelium after injury was shown not to correlate temporally to the increased transduction susceptibility of the epithelium. Although basal cells were the cell type transduced at the time of vector delivery, with time, basal cell differentiation to columnar cells occurred with maintenance of transgene expression. Collectively, these results show that murine and human cartilaginous airways are poorly transduced by AdV. To correct the cartilaginous airway CF bioelectrical defect in vivo, efforts should be directed to increase the tropism of AdV to the columnar airway epithelial cells.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.